Concepedia

DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity

Y. Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yongsheng Li, Haijun Deng, Zhiyong Shen

British Journal of Cancer · 2024 · 16 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 112.5K citations · Full text

, , +16

Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade

Ying Zhu, Jing Yang, Da Xu et al. · Gut · 2019 · 411 citations

, , +17

Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma

Julien Bollard, Verónica Miguela, Marina Ruiz de Galarreta et al. · Gut · 2016 · 297 citations · Full text

, , +17

Chapter 17 Messenger RNA Half‐Life Measurements in Mammalian Cells

Chyi‐Ying A. Chen, Nader Ezzeddine, Ann‐Bin Shyu · Methods in enzymology on CD-ROM/Methods in enzymology · 2008 · 258 citations · Full text

, , +11

DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells

Yizhou He, Khyati Meghani, Marie‐Christine Caron et al. · Nature · 2018 · 216 citations · Full text

, , +9